A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: blood loss (228), haemorrhage (88), flow (235)

Epirubicin (21) Ver 1.1

Description
Chemotherapy Protocol BREAST CANCER EPIRUBICIN (21 day) Regimen Breast Cancer – Epirubicin (21 day) Indication Treatment of locally advanced or metastatic breast
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastEpirubicin21Ver11.pdf

Doxorubicin (7) Ver1.1

Description
Chemotherapy Protocol BREAST CANCER DOXORUBICIN (7 day) Regimen Breast Cancer – Doxorubicin (7 day) Indication Treatment of locally advanced or metastatic breast
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastDoxorubicin7Ver11.pdf

Doxorubicin (21) Ver1.1

Description
Chemotherapy Protocol BREAST CANCER DOXORUBICIN (21 day) Regimen Breast Cancer – Doxorubicin (21 day) Indication Treatment of locally advanced or metastatic breast
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastDoxorubicin21Ver11.pdf

Cyclophosphamide-Epirubicin Ver 1.1

Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN Regimen Breast Cancer – Cyclophosphamide-Epirubicin Indication Primary systemic (neoadjuvant) therapy of breast cancer Adjuvant therapy
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Epirubicin-Ver-11.pdf

Cyclophosphamide-Doxorubicin Ver 1.1

Description
Regimen Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOXORUBICIN Breast Cancer – Cyclophosphamide-Doxorubicin Indication Primary systemic (neoadjuvant) therapy of breast cancer Adjuvant therapy
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Doxorubicin-Ver-1.1.pdf

Leisure activities after a head injury - patient information

Description
It's important to take care when you return to leisure activities after a head injury.
Url
/Media/UHS-website-2019/Patientinformation/Generalmedicine/Leisure-activities-after-a-head-injury-1948-PIL.pdf

Steroid treatment for premature babies - patient information

Description
Steroid treatment for premature babies Information for patients, parents and guardians We have given you this information l
Url
/Media/UHS-website-2019/Patientinformation/Childhealth/Steroid-treatment-for-premature-babies-2127-PIL.pdf

Ibrutinib

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia Regimen Ibrutinib • CLL – Ibrutinib Indication • NICE TA 429 r
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Ibrutinib.pdf

Cytarabine3000

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE (3000mg/m2) In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Cytarabine (3000mg/m2) Indication • Consolidation
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Cytarabine3000.pdf

AmsacrineCytarabineEtoposide_MACE

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA AMSACRINE-CYTARABINE-ETOPOSIDE In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Amsacrine-Cytarabine-Etoposide (MACE) Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AmsacrineCytarabineEtoposide-MACE.pdf
251 to 260 of 705
Previous … 24 25 26 27 28 … Next